Loading clinical trials...
Loading clinical trials...
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multi-Centre Study To Investigate The Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
Conditions
Interventions
Placebo
CP-690,550
+1 more
Locations
140
United States
ACRI - Phase 1, LLC
Anaheim, California, United States
Advanced Clinical Research Institute - Phase 1, LLC
Anaheim, California, United States
AGMG Endoscopy Center
Anaheim, California, United States
Alliance Clinical Research
Oceanside, California, United States
Alliance Clinical Research, LLC
Poway, California, United States
Sharp Rees-Stealy Medical Group, Inc.
San Diego, California, United States
Start Date
October 1, 2011
Primary Completion Date
February 1, 2015
Completion Date
March 1, 2015
Last Updated
April 28, 2017
NCT06226883
NCT07184931
NCT06918808
NCT06647615
NCT07377188
NCT07383844
Lead Sponsor
Pfizer
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions